Long-term incidence and tolerability of dyspnea in ticagrelor-treated acute coronary syndrome patients undergoing percutaneous coronary intervention:Insights into the GReekAntiPlatelet Registry(GRAPE)
Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome
Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study